We are live on ! Find out more
IMDZ

Immune Design Corp.
IMDZ

Delisted

IMDZ was delisted on the 1st of April, 2019.

Back to rankings

68 hedge funds and large institutions have $165M invested in Immune Design Corp. in 2019 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

838% more call options, than puts

Call options by funds: $75K | Put options by funds: $8K

324% more capital invested

Capital invested by funds: $39M → $165M (+$126M)

17% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 23

6% more funds holding

Funds holding: 64 → 68 (+4)

22% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 18

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
68
Holders Change
+4
Holders Change %
+6.25%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
27
Increased
14
Reduced
18
Closed
23
Calls
$75K
Puts
$8K
Net Calls
+$67K
Net Calls Change
+$67K

Top Buyers

Rank Fund Capital Flow
1
AAM
Alpine Associates Management
Florida
+$8.18M
2
TAL
TIG Advisors LLC
New York
+$6.87M
3
GF
Gabelli Funds
New York
+$4.47M
4
SAM
Sandell Asset Management
New York
+$4.43M
5
BCM
Beryl Capital Management
California
+$3.67M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$7.28M
2
BI
BVF Inc
California
-$6.74M
3
VVM
Versant Venture Management
California
-$2.87M
4
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$1.16M
5
PAM
Panagora Asset Management
Massachusetts
-$879K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCMT
26
Highland Capital Management (Texas)
Texas
$1.11M +$647K +190,000 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.06M +$3.74K +1,097 +0.6%
Deutsche Bank
28
Deutsche Bank
Germany
$1.03M +$451K +132,505 +301%
TCIM
29
TIAA CREF Investment Management
New York
$1.03M – – –
KPF
30
K2 Principal Fund
Ontario, Canada
$926K +$539K +158,255 New
LIM
31
Longfellow Investment Management
Massachusetts
$758K +$442K +129,630 New
HM
32
Harvest Management
New York
$527K +$307K +90,000 New
Charles Schwab
33
Charles Schwab
California
$474K +$61.3K +17,993 +29%
TA
34
Teachers Advisors
New York
$306K – – –
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$305K -$19.7K -5,777 -10%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$277K +$1.5K +440 +0.9%
GI
37
GAMCO Investors
Connecticut
$268K +$156K +45,885 New
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$267K +$35.8K +10,500 +30%
BCM
39
Bridgeway Capital Management
Texas
$248K – – –
PP
40
Paloma Partners
Connecticut
$233K +$136K +39,802 New
Goldman Sachs
41
Goldman Sachs
New York
$208K -$127K -37,342 -51%
PCM
42
Prelude Capital Management
New York
$193K +$112K +32,983 New
MS
43
Maven Securities
Jersey
$175K +$102K +30,000 New
VF
44
Virtu Financial
New York
$172K +$100K +29,460 New
PPA
45
Parametric Portfolio Associates
Washington
$166K +$96.8K +28,419 New
BFM
46
Boothbay Fund Management
New York
$159K – – –
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$137K +$79.9K +23,468 New
Barclays
48
Barclays
United Kingdom
$136K +$69.4K +20,362 +690%
AIG
49
American International Group
New York
$126K -$2.37K -696 -3%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$118K – – –
1
2
3 4

IMDZ Hedge Fund Activity: Q1 2019 in Review

68 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q1 2019, worth a combined $165M — up 324% from $39M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new IMDZ positions and 23 closed out — a net gain of 4 holders — while 14 added to existing stakes and 18 trimmed.

The largest buyer was Alpine Associates Management, opening a new position worth an estimated $8.18M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $7.28M sold.

  • 68 institutional investors held Immune Design Corp. (IMDZ) as of Q1 2019, up from 64 in Q4 2018.
  • Funds reported $165M of Immune Design Corp. stock for Q1 2019, up 324% quarter-over-quarter.
  • 27 funds opened new Immune Design Corp. positions in Q1 2019 and 23 closed out, a net change of +4 holders.
  • The largest Immune Design Corp. buyer in Q1 2019 was Alpine Associates Management, an estimated $8.18M added.
  • The largest Immune Design Corp. seller in Q1 2019 was EcoR1 Capital, an estimated $7.28M sold.

Based on aggregated 13F filings for Q1 2019.